Articles From: Covidien Announces 12-Month DEFINITIVE AR Results at VIVA 2014 to Cowen Group, Inc. Announces 2014 Third Quarter Financial Results


Covidien plc (NYSE: COV) today announced 12-month results of the DEFINITIVE AR study, the first randomized study designed to identify the clinical benefits of plaque removal using directional atherectomy followed by drug coated balloon.
Sign-up for Covidien Announces 12-Month DEFINITIVE AR Results at VIVA 2014 investment picks
Covidien plc (NYSE: COV) today announced, for purposes of the Irish Takeover Rules, that the definitive joint proxy statement of Covidien plc and Medtronic, Inc., which also serves as a prospectus of Medtronic Holdings Limited and comprises Covidien’s scheme circular required under Irish law is being sent today to Covidien and Medtronic, Inc., shareholders.
Sign-up for Covidien Announces Mailing of Definitive Joint Proxy Statement/Prospectus investment picks
Covidien plc (NYSE: COV) today announced nine-month results of the DURABILITY Iliac study and addition of the iliac indication for its EverFlex™ stent at the Vascular Interventional Advances (VIVA) 2014 conference.
Sign-up for Covidien Announces Nine-Month Results of DURABILITY Iliac Study, Addition of Iliac Indication for EverFlex™ Stent System at VIVA 2014 investment picks
Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.36 per ordinary share.
Sign-up for Covidien Declares Quarterly Cash Dividend investment picks
Covidien PLC (COV) filed a Form 8K - Other Events - with the U.S Securities and Exchange Commission on January 06, 2015.
Sign-up for Covidien Files 8K - Other Events investment picks
Covidien PLC (COV) filed a Form 8K - Other Events - with the U.S Securities and Exchange Commission on December 23, 2014.
Sign-up for Covidien Files 8K - Other Events investment picks
Covidien PLC (COV) filed a Form 8K - Other Events - with the U.S Securities and Exchange Commission on January 12, 2015.
Sign-up for Covidien Files 8K - Other Events investment picks
Covidien plc (NYSE:COV) today announced the launch of ReliaTack™ articulating reloadable fixation device, the first and only of its kind for laparoscopic (minimally invasive) hernia repair.
Sign-up for Covidien Launches First and Only Articulating Reloadable Absorbable Fixation Device for Minimally-Invasive Hernia Repair investment picks
Further underscoring its ongoing commitment to lung health, Covidien (NYSE:COV) today unveiled a next-generation version of its superDimension ™ Navigation System software.
Sign-up for Covidien Launches Next-Generation SuperDimension™ Lung Navigation Software to Simplify Planning, Enhance Visualization During a Procedure investment picks
Covidien plc (NYSE: COV) will report first-quarter fiscal 2015 results on January 22.
Sign-up for Covidien plc to Report First-Quarter Fiscal 2015 Results on January 22, 2015 investment picks
Covidien plc (NYSE: COV) today announced financial results for the fourth quarter of fiscal 2014.
Sign-up for Covidien Reports Fourth-Quarter and Fiscal 2014 Results investment picks
Covidien plc (NYSE: COV) today announced U.S. Food and Drug Administration 510(k) clearance for its Fortrex™ over-the-wire (OTW) percutaneous transluminal angioplasty (PTA) balloon catheter.
Sign-up for Covidien’s Fortrex™ PTA Balloon Receives FDA 510(k) Clearance investment picks
Covidien plc (NYSE: COV) today announced U.S. Food and Drug Administration 510(k) clearance for the HawkOne™ directional atherectomy system.
Sign-up for Covidien’s HawkOne™ Directional Atherectomy System Receives FDA 510(K) Clearance for the Treatment of Peripheral Arterial Disease investment picks
Covidien plc (NYSE:COV) today announced it has received CE Mark approval for its Stellarex™ drug-coated angioplasty balloon (DCB). The Stellarex™ DCB is used to restore and maintain blood flow to the arteries of the leg in patients with peripheral arterial disease (PAD). The Stellarex™ DCB is inserted into the diseased artery and inflated to open the vessel and restore blood flow, while a drug called paclitaxel is deposited onto the vessel wall to prevent the reoccurrence of new blockages.
Sign-up for Covidien’s Stellarex™ Drug-Coated Angioplasty Balloon Receives CE Mark to Treat Peripheral Arterial Disease Patients investment picks
2014/12/17
PillCam ® SB, Covidien’s wireless capsule endoscope, is now featured in the exhibit, “ Tools: Extending Our Reach ” at New York’s Cooper Hewitt Smithsonian Design Museum.
Sign-up for Covidien’s Unique Capsule Endoscopy PillCam® SB Featured in New Smithsonian Exhibit ‘Tools: Extending Our Reach’ investment picks
DETROIT, Jan.
Sign-up for Covisint Adds Rumba Solutions to Certified Partner Program investment picks
DETROIT, Jan.
Sign-up for Covisint Adds VisionIT to Certified Partner Program investment picks
Total revenue of $21.7 million Subscription revenue of $16.8 million Continued execution and progression on strategic initiatives to reposition business for growth DETROIT, Oct.
Sign-up for Covisint Corporation Announces Second Quarter Fiscal 2015 Earnings Results investment picks
DETROIT, Oct.
Sign-up for Covisint Corporation Names Homaira Akbari to Its Board of Directors investment picks
Cowen Group, Inc. (“Cowen”) (NASDAQ:COWN) today announced the formation of an information and technology services investment banking group and the appointment of Davies Beller and James Kissane as Managing Directors and Co-heads of the new group.
Sign-up for Cowen Announces Formation of Information and Technology Services Banking Group investment picks
Cowen Group, Inc. (“Cowen”) (NASDAQ:COWN) announced the release today of its investor relations app for iPhone, iPad and Android mobile devices now available for free at Apple’s App Store for the iPhone and iPad and at Google Play for Android mobile devices.
Sign-up for Cowen Group Launches Investor Relations App investment picks
Cowen Group, Inc. (NASDAQ:COWN) will host a conference call on November 6, 2014 at 9:00 AM Eastern Time to discuss the Company's financial results for the 2014 third quarter.
Sign-up for Cowen Group, Inc. Announces 2014 Third Quarter Earnings Conference Call investment picks
Cowen Group, Inc. (NASDAQ:COWN) (“Cowen” or “the Company”) today announced its operating results for the third quarter ended September 30, 2014.
Sign-up for Cowen Group, Inc. Announces 2014 Third Quarter Financial Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Covidien Announces 12-Month DEFINITIVE AR Results at VIVA 2014 to Cowen Group, Inc. Announces 2014 Third Quarter Financial Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent